AssayQuant Technologies: Funding, Investors & Team (Oct 2026)
AssayQuant Technologies is a company in the field of life sciences that develops new and improved enzyme assay formats to enhance performance and productivity. The primary focus of AssayQuant is to create assays for monitoring the activity of over 500 protein kinases, which play a role in many disease conditions and contribute to 30% of the entire drug development process. The flagship product of AssayQuant, called PhosphoSens, is a state-of-the-art sensor platform based on Sox technology. This platform utilizes a technology developed by the Imperiali laboratory at MIT and licensed to AssayQuant. PhosphoSens offers a straightforward solution for quantifying the activity of protein kinases and phosphatases, specifically targeting Tyr, Ser/Thr, or Mixed Function, through a single-step, homogeneous, and continuous format.
AssayQuant Technologies has raised $5.1M across 1 funding round on record, the most recent an undisclosed round of $5.1M announced in Jul 2023.
That round is below the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
AssayQuant Technologies Company Profile and Key Stats
Latest funding round on record: Jul 2023.
AssayQuant Technologies Funding Rounds
AssayQuant Technologies Founders and Leadership Team
No contact details are on record for this team yet.
AssayQuant Technologies Funding Compared to Other Biotechnology Startups
AssayQuant Technologies' latest round of $5.1M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like AssayQuant Technologies in Biotechnology and Marlborough
Companies Similar to AssayQuant Technologies
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…
Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…
AssayQuant Technologies Funding FAQs
What does AssayQuant Technologies do?
AssayQuant Technologies is a company in the field of life sciences that develops new and improved enzyme assay formats to enhance performance and productivity. The primary focus of AssayQuant is to create assays for monitoring the activity of over 500 protein kinases, which play a role in many disease conditions and contribute to 30% of the entire drug development process. The flagship product of AssayQuant, called PhosphoSens, is a state-of-the-art sensor platform based on Sox technology. This platform utilizes a technology developed by the Imperiali laboratory at MIT and licensed to AssayQuant. PhosphoSens offers a straightforward solution for quantifying the activity of protein kinases and phosphatases, specifically targeting Tyr, Ser/Thr, or Mixed Function, through a single-step, homogeneous, and continuous format.
How much funding has AssayQuant Technologies raised?
AssayQuant Technologies has raised $5.1M across 1 round on record. The most recent is an undisclosed round of $5.1M announced in Jul 2023.
When did AssayQuant Technologies last raise funding?
AssayQuant Technologies' most recent funding round on record is an undisclosed round of $5.1M, announced in Jul 2023.
Who founded AssayQuant Technologies?
FundedIQ lists Barbara Imperiali (Founder) at AssayQuant Technologies.
Where is AssayQuant Technologies headquartered?
AssayQuant Technologies is based in Marlborough, Massachusetts, United States.
How many employees does AssayQuant Technologies have?
AssayQuant Technologies is in the 11-50 employee band.
How does AssayQuant Technologies' funding compare to other Biotechnology startups?
AssayQuant Technologies' latest round of $5.1M is below the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's AssayQuant Technologies Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for AssayQuant Technologies is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.